01074nas a2200337   4500000000100000000000100001008004100002653003100043653002800074653004000102653002600142653003000168653001100198653002700209653003000236653005700266653008000323653002200403653001900425653001400444653002200458653002400480100001400504700002000518700001300538245011800551250001500669300001400684490000700698020003100705       2022                            d10aAdministration, Inhalation10aAdrenal Cortex Hormones10aAdrenergic beta-2 Receptor Agonists10aBronchodilator Agents10aDrug Therapy, Combination10aHumans10aMuscarinic Antagonists10aNebulizers and Vaporizers10a*Pneumonia/chemically induced/diagnosis/epidemiology10a*Pulmonary Disease, Chronic Obstructive/diagnosis/drug therapy/epidemiology10aCOPD exacerbation10aCohort Studies10apneumonia10apropensity scores10areal-world evidence1 aS. Suissa1 aS. Dell'Aniello1 aP. Ernst00aSingle-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety  a2022/09/07  a1975-19860 v17  a1176-9106 (Print)1176-9106